30d • General discussion
5-Amino-1MQ: The NNMT Inhibitor Turning Heads
❇️ If you've been following the metabolic peptide space lately, you've probably seen 5-Amino-1MQ pop up more and more. It's not a traditional peptide — it's a small molecule — but it's earned its place in research circles for one very compelling reason: it targets an enzyme called NNMT, and the downstream effects are seriously interesting.
❇️So What Is NNMT, and Why Does It Matter?
NNMT stands for Nicotinamide N-Methyltransferase — an enzyme that methylates nicotinamide (a form of vitamin B3), effectively pulling methyl groups away from the metabolic pool and reducing NAD+ availability. When NNMT is overactive (which it tends to be in obese and insulin-resistant individuals), it acts like a metabolic brake. You get lower NAD+, slower mitochondrial function, and a harder time burning fat.
👉🏼 5-Amino-1MQ blocks NNMT. That's its whole job — and by doing so, it lets NAD+ levels rise naturally.
❇️ What the Research Shows
🔸 Preclinical studies have highlighted some notable effects:
➡ Fat loss without caloric restriction: In mouse models, NNMT inhibition led to significant reductions in body fat, even without changes to diet. The mechanism appears tied to increased energy expenditure at the cellular level.
➡ NAD+ elevation: Higher NAD+ means more fuel for sirtuins (especially SIRT1) and improved mitochondrial efficiency — both linked to longevity and metabolic health.
➡ Muscle preservation: Unlike aggressive caloric deficits that chew through lean mass, NNMT inhibition appears to preferentially target adipose tissue.
➡ Improved insulin sensitivity: Early data suggests better glucose handling, which is particularly relevant for metabolic syndrome research.
❇️How It's Different From NAD+ Precursors:
You might be thinking: "Why not just take NMN or NR?" Fair question. Those work by directly adding NAD+ precursors to the system. 5-Amino-1MQ works differently — it removes the enzyme that's draining NAD+ in the first place. Think of it less like adding water to a leaky bucket and more like patching the hole. Some researchers believe this makes it especially relevant for metabolically compromised models where NNMT is chronically upregulated.
🧬 Research Protocols
The following reflects dosing and administration patterns observed in preclinical and early research settings:
✅ Typical studied dose range: 50–150 mg per day in oral formulations used in rodent studies; human-equivalent doses are still being extrapolated.
⏱️ Frequency: Once daily dosing has been the most common protocol in available research, typically administered in the morning.
🔸Route of administration:
💊 Oral (capsule or solution) — 5-Amino-1MQ demonstrates reasonable oral bioavailability in preclinical pharmacokinetic studies.
💉 Injectable - there is much debate about the dosing, some protocols say 10 to 50mg daily, however, new trends tend to lean towards: 1-2 mg 1-2 times a week for 4-6mo
🔁 Cycle length: Research protocols have ranged from 4 to 12 weeks. Longer durations have not been well characterized in published literature.
👉🏼 Stacking notes: Some research models have explored 5-Amino-1MQ alongside NAD+ precursors (NMN or NR) to assess additive effects on cellular energy metabolism. Pairing with GLP-1 receptor agonists has also been theorized for synergistic metabolic benefit, though direct combination data is limited.
❇️ Where the Research Currently Stands
It's important to be clear: 5-Amino-1MQ is a research compound. The bulk of available data comes from rodent studies, with human clinical trials still limited. Oral bioavailability appears promising based on preclinical pharmacokinetics, and it's typically studied in low nanomolar doses. Half-life and long-term safety profiles in humans are still being characterized.
✅ Bottom Line
5-Amino-1MQ is one of the more mechanistically elegant compounds in the current research landscape. Rather than flooding the system with a substrate, it targets an upstream regulator and lets the body do the rest. For researchers focused on metabolic health, body composition, or NAD+ biology, it's a compound worth watching closely as human data continues to develop.
This article is for educational purposes only. All compounds discussed are for research use only and are not approved for human use. Nothing in this article constitutes medical advice. Always consult a licensed healthcare professional before making any health decisions.
4
8 comments
5-Amino-1MQ: The NNMT Inhibitor Turning Heads
powered by
skool.com/peptide-resource-center-3431
We are here for you because we've been there. Get support, education, resources and more!!!
Suggested communities
Powered by